Gross and fine motor skills in children treated for acute lymphoblastic leukaemia. (June 2013)

• Record Type: Journal Article
• Authors: De Luca, Cinzia R.; McCarthy, Maria; Galvin, Jane; Green, Jessica L.; Murphy, Alexandra; Knight, Sarah; Williams, Jacqueline
• Is Part Of: Developmental neurorehabilitation. Volume 16:Number 3(2013:Jun.)
• Page Start: 180
• Page End: 187
• Publication Date: 2013-06
• Subjects: Children with disabilities -- Rehabilitation -- Periodicals; Developmentally disabled children -- Rehabilitation -- Periodicals; 615.542
• DOI: 10.3109/17518423.2013.771221
• Languages: English
• ISSNs: 1751-8423

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p> <italic>Objective</italic>: Chemotherapy treatment for acute lymphoblastic leukaemia (ALL) may disrupt motor development, with suggestions that gross and fine motor deficits are different depending on time since treatment.</p> <p> <italic>Methods</italic>: Thirty-seven participants aged between 2.5 to 5 years at the time of diagnosis were assessed using the Movement Assessment Battery for Children, 2nd Edition (MABC-2) and the Bruininks–Oseretsky Test of Motor Proficiency, 2nd Edition, Short Form (BOT-2 SF), and divided into groups (i.e. months-off-treatment): (1) 0–12, (2) 13–24, and (3) 25–60 for comparison.</p> <p> <italic>Results</italic>: MABC-2 and BOT-2 SF mean total scores fell within the average range. Twenty-six percent of the sample performed in the impaired range on the MABC-2. Group 2 had significantly lower Manual Dexterity scores than the normative population and lower BOT-2 SF scores than Group 1.</p> <p> <italic>Conclusion</italic>: Most children treated for ALL display appropriate motor skills, yet around a quarter experience general motor difficulties. Time-off-treatment did not affect the prevalence of motor impairments on any measure.</p> </abstract>